Selected Publications
S Mohan, S Wang, G Coban, F Kural, S Chawla, D O’Rourke, H Poptani: Detection of Occult Neoplastic Infiltration in the Corpus Callosum and Prediction of Overall Survival in Patients with Glioblastoma using Diffusion Tensor Imaging European Journal of Radiology : 2019 .
Saxena D, Sheikh S, Kao G, Binder ZA, Alonso-Basanta M, O'Rourke DM, Nasrallah MP, Dorsey JF: Rapid and ultrasensitive digital PCR (dPCR) profiling of EGFRvIII in tumor cells and tissues. Neurooncol Adv 1 (1): vdz030,2019.
Jacob F, Salinas RD, Zhang DY, Ngyuen PTT, Schnoll JG, Wong SGH, Thokala R, Sheikh S, Saxena D, Prokop S, Liu D, Qian X, Petrov D, Lucas T, Chen HI, Dorsey JF, Christian KM, Binder ZA, Nasrallah M, Brem S, *Ming G-l, *Song H, *O'Rourke DM (*corresponding): A Patient-Derived Glioblastoma Organoid Model and Biobank Recapitulates Inter- And Intra-tumoral Heterogeneity Cell : 2019.
Makhlin I, Salinas RD, Zhang D, Jacob F, Ming GL, Song H, Saxena D, Dorsey JF, Nasrallah MP, Morrissette JJ, Binder ZA, O'Rourke DM, Desai AS, Brem S, Bagley SJ.: Clinical activity of the EGFR tyrosine kinase inhibitor osimertinib in EGFR-mutant glioblastoma. CNS Oncol 8 (3): 2019.
Martinez-Lage M, Lynch TM, Bi Y, Cocito C, Way GP, Pal S, Haller J, Yan RE, Ziober A, Nguyen A, Kandpal M, O'Rourke DM, Greenfield JP, Greene CS, Davuluri RV, Dahmane N: Immune landscapes associated with different glioblastoma molecular subtypes. Acta Neuropathol Commun 7 (1): 203,2019.
Bagley S, Nabavizadeh SA, Mays J, Till JE, Ware J, Levy S, Sarchiapone W, Hussain J, Prior TJ, Guiry S, Christensen T, Yee SS, Nasrallah M, Morrissette JJ, Binder Z, O'Rourke DM, Cucchiara AJ, Brem S, Desai AS, Carpenter EL: Clinical utility of plasma cell-free DNA in adult patients with newly diagnosed glioblastoma - a pilot prospective study. Clin Cancer Res : 2019.
Hoffman DI, Abdullah KG, McCoskey M, Binder ZA, O'Rourke DM, Desai AS, Nasrallah MP, Bigdeli A, Morrissette JJD, Brem S, Bagley SJ: Negative prognostic impact of epidermal growth factor receptor copy number gain in young adults with isocitrate dehydrogenase wild-type glioblastoma. J Neurooncol : 2019.
Wen PY, Reardon DA, Armstrong TS, Phuphanich S, Aiken RD, Landolfi JC, Curry WT, Zhu JJ, Glantz M, Peereboom DM, Markert J, LaRocca R, O'Rourke DM, Fink K, Kim L, Gruber M, Lesser GJ, Pan E, Kesari S, Muzikansky A, Pinilla C, Santos RG, Yu JS: A Randomized Double-Blind Placebo-Controlled Phase 2 Trial Of Dendritic Cell Vaccine ICT-107 In Newly Diagnosed Patients With Glioblastoma. Clin Cancer Res : pii: clincanres.0261.2019,2019.
Nabavizadeh SA, Akbari H, Ware JB, Nasrallah M, Guiry S, Bagley SJ, Desai A, Levy S, Sarchiapone W, Prior T, Detre J, Wolf RL, O'Rourke DM, Brem S, Davatzikos C: Arterial Spin Labeling and Dynamic Susceptibility Contrast-enhanced MR Imaging for evaluation of arteriovenous shunting and tumor hypoxia in glioblastoma. Sci Reports 9 (1): 8747,2019.
Ramayya AG, Chen HI, Marcotte PJ, Brem S, Zager EL, Osiemo B, Piazza M, Sharma N, McClintock SD, Schuster JM, Ali ZS, Connolly P, Heuer GG, Grady MS, Kung DK, Ozturk AK, O'Rourke DM, Malhotra NR: Assessing variability in surgical decision making among attending neurosurgeons at an academic center. J Neurosurg : 1-7,2019.
View all publications
Academic Contact Information
HUP - 3 Silverstein
3400 Spruce Street
Philadelphia,
PA
19104
Phone: (215) 662-3490
Patient appointments: 800-789-7366